Where does Actym Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Actym Therapeutics, Inc. ranks #30,738 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Actym Therapeutics, Inc. hold?

Actym Therapeutics, Inc. holds 8 US utility patents granted between 2021 and 2025, spanning 6 technology areas.

What is Actym Therapeutics, Inc.'s Innovation Score?

Actym Therapeutics, Inc. has an Innovation Score of 51.3 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Actym Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Actym Therapeutics, Inc..

What does claim depth mean for Actym Therapeutics, Inc.'s patents?

Actym Therapeutics, Inc.'s patents average 39.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Actym Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Actym Therapeutics, Inc.

Q: What technology areas does Actym Therapeutics, Inc. focus on?

Actym Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 8 patents, ranking #1,253 of 4,144 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Actym ranks #30,738 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 6 technology areas.

#30,738
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.3/100): 39.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30738 · US Corporation #30,738 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #30,738/49,997
PHOTO-FINISH Acer Cyber Security…
CPC-NARROW C12N · 6 areas
INNOV-PAR 51.3/100
CLAIMS-DENSE 39.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Acer Cyber Security Incorporated (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Actym’s 51.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (15%) Velocity 20.0 pts (39%) Breadth 8.7 pts (17%) Claim depth 15.0 pts (29%)

Qualcomm Incorporated · highest

85
Smartsens TECHNOLOGY… · near

51
Actym Therapeutics · this assignee

51
Spatial Transcriptom… · near

51
Veir · near

51
Water Harvesting · near

51
3D Lighting… · lowest

7

What this shows Actym's Innovation Score is 51.3/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Actym?

Each dot is one of Actym’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Actym’s own 39.9 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Actym vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Actym's grants concentrate

Actym Therapeutics, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2021. By volume, Actym sits between Acer Cyber Security Incorporated and Adensis GmbH.

Actym's three-year grant acceleration

Actym Therapeutics, Inc. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Acer Cyber Securi…

8
Achilles

8
Acquist

8
Actervis

8
Acuant

8
Adcura

8
Adenda Media

8
Adensis

8
Actym Therapeutics ◀

8

What this shows Actym holds 8 patents at rank #30,850, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Actym

By rank, the assignees closest to #30,850 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Actym's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Actym, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Actym ranks #1,253 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Spatial Transcriptomics AB 51 Veir, Inc. 51 Water Harvesting, Inc. 51 Smartsens TECHNOLOGY(HK) Co., Limited 51

Actym's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Actym Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	12.5%
2022	1	12.5%
2023	1	12.5%
2024	2	25.0%
2025partial year	3	37.5%

Which technologies does Actym Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

C07K - Peptides 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 5

Y02A - Technologies FOR Adaptation TO Climate Change 5

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Actym Therapeutics, Inc.'s patent record in context - here's where to go next.

Actym Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #30,738 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Actym Therapeutics, Inc. against Acer Cyber Security Incorporated, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.